Ready to make mealtimes less stressful and feel in control again?
The recently published FLOW trial, which specifically targeted T2DM patients with CKD and used kidney-specific primary endpoints, has solidified the efficacy of GLP-1 RAs in slowing CKD progression [58]
While tirzepatide effectively reduces appetite through central and peripheral mechanisms, patients may unconsciously increase portion sizes, caloric density of foods, or eating frequency as initial gastrointestinal side effects diminish
Kisspeptin stimulates GnRH neurons, increasing LH and triggering ovulation
(2006) Single-blind, multicenter, placebo controlled, parallel study to assess the safety and efficacy of intralesional interferon alpha-2B for minimally invasive treatment for Peyronie's disease
When compounds are inconsistent or unverified, experiments can lose accuracy and valuable time